British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints. - Wikidata - wikimedia - TriplyDB

British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

http://www.wikidata.org/entity/Q35137989

about

Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy.

P2860

Q41110861-997C050C-F92E-495B-B738-F38440AF1A07

P2860

British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

http://www.wikidata.org/entity/Q35137989

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

British randomised controlled ...... ionale, design, and endpoints.

@ast

British randomised controlled ...... ionale, design, and endpoints.

@en

type

label

British randomised controlled ...... ionale, design, and endpoints.

@ast

British randomised controlled ...... ionale, design, and endpoints.

@en

prefLabel

British randomised controlled ...... ionale, design, and endpoints.

@ast

British randomised controlled ...... ionale, design, and endpoints.

@en

P1433

Q35137989-00728CB0-82F0-445E-8E83-4585AF2F1BA4

P1476

Q35137989-4DF59895-04E7-4C79-9B8C-5ED41CEAC19B

P2093

Q35137989-2086037A-56C3-49A6-B034-05D8F892CA7B

Q35137989-268CC3E3-BBC9-4EE0-A808-A9FA65B24BC4

Q35137989-2A024315-F3BD-4382-946B-CFF3296F0E7D

Q35137989-55D4003B-6388-4CC5-A4E3-6247E66F0DC3

Q35137989-59FDAFA6-D6C1-48B3-8046-7B4CDDBE55FC

Q35137989-71D9034A-1263-4BCD-A04A-68EF32507583

Q35137989-98550BDE-1D38-453C-B87B-86C7B019B95C

Q35137989-E4D53BF2-32EB-40B6-8E76-5870A632B0D8

Q35137989-EEBCFFEE-FBA4-4CC2-A22C-0D560AE56330

P2860

Q35137989-019B765C-981C-48CB-A717-7A1F83F11A93

Q35137989-02B20153-9FDB-47CF-A4FA-F40E3956FFE2

Q35137989-072577EA-76B2-4603-A9AD-809EEF51A926

Q35137989-0838EE69-8420-48CF-8B2D-1909BFC4E33F

Q35137989-14CF50D8-FEA7-4397-908D-ECCF19C46DD9

Q35137989-19B88D39-9694-4154-AFAB-754EE09F0D91

Q35137989-1A4D3DD6-67C2-46D1-9019-E49697E8E075

Q35137989-1ADB8D4A-4EE6-4403-B7CC-A846FA29B1BC

Q35137989-2AD62B51-4436-4E18-9C51-691AAE4D5A6A

Q35137989-332BF305-9EC9-40D4-A56B-AF96E8A7276E

P2888

Q35137989-C7C1D2B1-56C7-4FC7-83BB-D0C2B00376E7

P304

Q35137989-F8F6E289-BD47-477E-A19E-1B5719006793

P31

Q35137989-3813E890-8112-4D3E-87B2-CD666EDD7175

P356

Q35137989-32A6FC18-7FFC-4595-9C2F-2C61C43EBD42

Q35137989-78B21939-9447-400A-B89D-710DEAD6BE58

P478

Q35137989-936F5CBB-A7F2-427C-AC38-409B846C92AB

P50

Q35137989-65F62A9B-237D-4030-9D52-61A31D57B59F

Q35137989-768B7B20-11CE-469F-9712-A5BE2D3C257E

P577

Q35137989-690C678F-9AF0-40AE-B52D-91FB8A56FDCF

P6179

Q35137989-FEBC7AD0-DD4C-4F85-A21E-AB9F2DA0B038

P698

Q35137989-47C02E7F-46C7-445A-9034-E8E1B452ED29

P932

Q35137989-0D839F75-B2B1-4B3D-95AC-F3C3F066A4ED

P356

S15027-014-0357-4

1471-2261-14-42

P1433

BMC Cardiovascular Disorders

P1476

British randomised controlled ...... ionale, design, and endpoints.

@en

P2093

Andreas Kyriacou

http://www.w3.org/2001/XMLSchema#string

BRAVO Investigators

http://www.w3.org/2001/XMLSchema#string

Darrel P Francis

http://www.w3.org/2001/XMLSchema#string

Emma Coady

http://www.w3.org/2001/XMLSchema#string

Jamil Mayet

http://www.w3.org/2001/XMLSchema#string

Katherine March

http://www.w3.org/2001/XMLSchema#string

Michael Frenneaux

http://www.w3.org/2001/XMLSchema#string

S M Afzal Sohaib

http://www.w3.org/2001/XMLSchema#string

Zachary I Whinnett

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of non-invasive continuous finger blood pressure measurement (Finapres) with intra-arterial pressure during prolonged head-up tilt.

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Cardiac resynchronization in chronic heart failure.

Optimal medical therapy with or without PCI for stable coronary disease.

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography.

Prognostic value of gated myocardial perfusion SPECT.

Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay

Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.

The acute effects of changes to AV delay on BP and stroke volume: potential implications for design of pacemaker optimization protocols.

P2888

s15027-014-0357-4

P304

42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S15027-014-0357-4

http://www.w3.org/2001/XMLSchema#string

10.1186/1471-2261-14-42

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026487222

http://www.w3.org/2001/XMLSchema#string

P698

24693953

http://www.w3.org/2001/XMLSchema#string

P932

3992145

http://www.w3.org/2001/XMLSchema#string